⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
globenewswire.com
EDAP
TLX
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AZN
MRK
JNJ
PFE
ABBV
GSK
ALLR
SNY
CURI
ORIC
EXEL
ABSI
LLY
TLX
FPH
BMY
SNX
XNCR
ZENA
ARVN
MGNX
DASH
VERU
GILD
EVGN
GEN
AMGN
MIR
RXRX
BG
MTX
BIO
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
globenewswire.com
TLX
TLX101-Px (Pixlumi®) MAA Accepted in Europe
globenewswire.com
TLX
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
globenewswire.com
TLX
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
globenewswire.com
TLX
Bone Metastasis in Solid Tumors Market Research and Global Long-term Forecast Report 2025-2035 Featuring Mabwell Bioscience, Novartis, Telix Pharmaeuticals, Sichuan Kelun-Biotech
globenewswire.com
NVS
TLX
ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026
globenewswire.com
TLX
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
globenewswire.com
TLX
Telix Successfully Prices and Upsizes US$600 Million Convertible Bonds USA - English APAC - English
prnewswire.com
TLX